Clinical trial

Benzoylphenylurea in Treating Patients With Advanced Solid Tumors

NCT00016354 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Completed

Key facts

NCT number NCT00016354
Title Benzoylphenylurea in Treating Patients With Advanced Solid Tumors
Official title Phase I Study of Continuous Weekly Dosing of Dimethyl Benzoylphenylurea (BPU) in Patients With Solid Tumors Not Responding to Conventional Therapy
Lead sponsor Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 1
Study type Interventional
Conditions Unspecified Adult Solid Tumor, Protocol Specific
Intervention type Drug
Interventions benzoylphenylurea
Enrollment 19
Start date Mar 1, 2001
Primary completion Aug 1, 2004
Completion Sep 1, 2006
First posted Jan 27, 2003
Last update posted Mar 25, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies